In this study, we analyzed the prognostic significance of PLP2 expression in MM patients using IHC analysis and GEO datasets and correlated with markers of myeloma activity, such as lower serum levels of ALB, higher serum levels of β2-MG, LDH, and CRP. The gene discussed is PLP2; the disease is plasma cell myeloma.